Development of a membrane adsorber based capture step for the purification of yellow fever virus

Vaccine

Volumn 32, Issue 24, 2014, Pages 2789-2793

  Pato, Tânia P ^a,b   Souza, Marta Cristina O ^a   Silva, Andréa N M R ^a   Pereira, Renata C ^a   Silva, Marlon V ^a   Caride, Elena ^a   Gaspar, Luciane P ^a   Freire, Marcos S ^a   Castilho, Leda R ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ENVELOPE PROTEIN; INACTIVATED VACCINE;

ALKALINITY; ANION EXCHANGE; ARTICLE; CELL CULTURE; CLINICAL EVALUATION; COMPUTER MODEL; CONTROLLED STUDY; ELUTION; INFECTION CONTROL; MEMBRANE; MOLECULAR STABILITY; NONHUMAN; PH; PRIORITY JOURNAL; PRODUCT RECOVERY; Q MEMBRANE; VERO CELL LINE; VIRUS ATTACHMENT; VIRUS PURIFICATION; YELLOW FEVER FLAVIVIRUS;

ADSORPTION; ANIMALS; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, ION EXCHANGE; HYDROGEN-ION CONCENTRATION; MEMBRANES; VERO CELLS; VIRUS CULTIVATION; YELLOW FEVER VIRUS;

EID: 84899915956     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.036     Document Type: Article

References (18)

1. Monath T.P., Lee C.K., Julander J.G., Brown A., Beasley D.W., Watts D.M., et al. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine 2010, 28:3827-3840.
2. Gardner C.L., Ryman K.D. Yellow fever: a reemerging threat. Clinical Laboratory Medicine 2010, 30:237-260.
3. Souza M.C., Freire M.S., Schulze E.A., Gaspar L.P., Castilho L.R. Production of yellow fever virus in microcarrier-based Vero cell cultures. Vaccine 2009, 27:3420-6423.
4. Conference report. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France. Vaccine 2007, 25:2758-2765.
5. Freire M.S., Mann G.F., Marchevsky R.S., Yamamura A.M.Y., Almeida L.F.C., Jabor A.V., et al. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Vaccine 2005, 23:2501-2512.
6. Vicente T., Mota J.P.B., Peixoto C., Alves P.M., Carrondo M.J.T. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances. Biotechnology Advances 2011, 29:869-878.
7. Forcic D., Brgles M., Ivancic-Jelecki J., Šantak M., Halassy B., Barut M., et al. Concentration and purification of rubella virus using monolithic chromatographic support. Journal of Chromatography B 2011, 879:981-986.
8. Rodrigues T., Carrondo M.J.T., Alves P.M., Cruz P.E. Purification of retroviral vectors for clinical application: biological implications and technological challenges. Journal of Biotechnology 2007, 127:520-541.
9. Vicente T., Sousa M.F.Q., Peixoto C., Motab J.P.B., Alves P.M., Carrondo M.J.T. Anion-exchange membrane chromatography for purification of rotavirus-like particles. Journal of Membrane Science 2008, 311:270-283.
10. Czermak P., Grzenia D.L., Wolf A., Carlson J.O., Specht R., Han B., et al. Purification of the densonucleosis virus by tangential flow ultrafiltration and by ion exchange membranes. Desalination 2008, 224:23-27.
11. Vogel J.H., Nguyen H., Giovannini R., Ignowski J., Garger S., Salgotra A., et al. A new large-scale manufacturing platform for complex biopharmaceuticals. Biotechnology and Bioengineering 2012, 109(12):3049-3058.
12. Kalbfuss B., Wolff M., Geisler L., Tappe A., Wickramasinghe R., Thom V., et al. Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. Journal of Membrane Science 2007, 299:251-260.
13. GE Healthcare strategies for protein purification handbook; 2010.
14. Caufour P.S., Motta M.C., Yamamura A.M., Vazquez S., Ferreira I.I., Jabor A.V., et al. Construction, characterization and immunogenicity of recombinant yellow fever 17 D-dengue type 2 viruses. Virus Research 2001, 79:1-14.
15. Fields B.N., Knipe D.M., Howley P.M. Fields virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. Fifth ed.
16. World Health Organization WHO Study Group on cell substrates for production of biologicals 2007, WHO Headquarters, Geneva.
17. Wolter T., Richter A. Assays for controlling host-cell impurities in biopharmaceutical. Bioprocess International 2005, February.
18. Champion K., Madden H., Dougherty J., Shacter E. Defining your product profile and maintaining control over it: Part 2. Challenges of monitoring host cell protein impurities. Bioprocess International 2005, September.